Related Experiment Video
Updated: May 22, 2026
11:20
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Bisindoylmaleimide I enhances osteogenic differentiation
Fangfang Zhou1, Huizhe Huang, Long Zhang
1Department of Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Protein & Cell
|May 3, 2012
Summary
Bisindoylmaleimide I (BIM) activates Wnt/β-catenin signaling, promoting osteoblast differentiation and bone formation. This compound enhances mesenchymal stem cell osteogenesis, offering a new strategy for bone regeneration.
Area of Science:
- Biochemistry
- Cell Biology
- Regenerative Medicine
Background:
- Wnt/β-catenin and bone morphogenetic proteins (BMPs) pathways are crucial for osteogenesis.
- Understanding signaling pathway integration is key for bone formation research.
Purpose of the Study:
- To identify novel regulators of osteogenesis.
- To investigate the role of bisindoylmaleimide I (BIM) in osteoblast differentiation and bone formation.
Main Methods:
- Cell-based kinase inhibitor screening assay.
- Analysis of β-catenin accumulation and transcriptional activity.
- Functional assays for osteoblast differentiation and bone formation in vitro.
- Treatment of human mesenchymal stem cells (hMSCs) with BIM.
Main Results:
- Bisindoylmaleimide I (BIM) was identified as a potent agonist of cytosolic β-catenin accumulation in preosteoblast cells.
- BIM suppressed glycogen synthase kinase 3β (GSK3β) activity, upregulating β-catenin signaling and extending BMP-initiated signals.
- BIM treatment promoted osteoblast differentiation and enhanced bone formation.
- BIM treatment of hMSCs stimulated osteoblastogenesis.
Conclusions:
- Bisindoylmaleimide I (BIM) promotes osteogenesis by modulating Wnt/β-catenin and BMP signaling pathways.
- BIM is a potential therapeutic agent for enhancing bone formation and treating bone-related disorders.
- Integrating cellular signaling pathways offers a novel strategy for regulating mesenchymal stem cell differentiation.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...